Suppr超能文献

Use of Discharge Disposition to Determine Stroke Severity After TAVR.

作者信息

Butala Neel M, Kapadia Samir R, Yeh Robert W, Cohen David J

机构信息

Division of Cardiology, Rocky Mountain Regional VA Medical Center, Aurora, CO (N.M.B.).

Division of Cardiology, University of Colorado School of Medicine, Aurora (N.M.B.).

出版信息

Circ Cardiovasc Interv. 2024 Sep;17(9):e013698. doi: 10.1161/CIRCINTERVENTIONS.123.013698. Epub 2024 Jun 5.

Abstract
摘要

相似文献

1
Use of Discharge Disposition to Determine Stroke Severity After TAVR.
Circ Cardiovasc Interv. 2024 Sep;17(9):e013698. doi: 10.1161/CIRCINTERVENTIONS.123.013698. Epub 2024 Jun 5.
2
5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
JACC Cardiovasc Imaging. 2025 Jun;18(6):625-640. doi: 10.1016/j.jcmg.2025.01.015. Epub 2025 Apr 16.
4
Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials.
JACC Cardiovasc Interv. 2025 Jun 23;18(12):1540-1553. doi: 10.1016/j.jcin.2025.03.036.
7
Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial.
Circ Cardiovasc Interv. 2025 Jan;18(1):e014592. doi: 10.1161/CIRCINTERVENTIONS.124.014592. Epub 2025 Jan 21.
8
Mid-Term Outcomes of Balloon-Expandable Aortic Valve-in-Valve Replacement in the United States.
JACC Cardiovasc Interv. 2025 Aug 25;18(16):1989-2000. doi: 10.1016/j.jcin.2025.06.039.
9
Stroke volume index (SVI) predicts all-cause mortality following transcatheter aortic valve replacement (TAVR).
Cardiovasc Revasc Med. 2025 Mar;72:38-43. doi: 10.1016/j.carrev.2024.06.014. Epub 2024 Jun 17.

引用本文的文献

1
Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve Replacement.
Circ Cardiovasc Qual Outcomes. 2025 May;18(5):e011991. doi: 10.1161/CIRCOUTCOMES.125.011991. Epub 2025 Mar 29.
2
Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial.
Circ Cardiovasc Interv. 2025 Jan;18(1):e014592. doi: 10.1161/CIRCINTERVENTIONS.124.014592. Epub 2025 Jan 21.
3
Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry.
Circ Cardiovasc Interv. 2024 Sep;17(9):e013697. doi: 10.1161/CIRCINTERVENTIONS.123.013697. Epub 2024 Jun 5.

本文引用的文献

1
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
N Engl J Med. 2022 Oct 6;387(14):1253-1263. doi: 10.1056/NEJMoa2204961. Epub 2022 Sep 17.
2
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595.
4
Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement.
JACC Cardiovasc Interv. 2019 Feb 25;12(4):362-369. doi: 10.1016/j.jcin.2018.11.008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验